What percentage of breast cancer is detected through screening in Africa?
Best insight from top research papers
In Africa, the percentage of breast cancer detected through screening varies across different countries. Studies have shown that the overall proportion of survey participants who underwent clinical breast cancer screening was 16.3% in selected sub-Saharan African countries . The prevalence of breast cancer screening during the study period ranged from 5.2% in Ivory Coast to 23.1% in Namibia . Clinical Breast Examination (CBE) and mammography were the most common screening modalities evaluated, with detection rates ranging from < 1/1000 to 3.3/1000 for CBE and 3.3/100 to 56/1000 for mammography screening . Despite the high breast cancer mortality rates in sub-Saharan Africa, the prevalence of breast cancer screening remains substantially low, emphasizing the urgent need to enhance screening uptake in the region .
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| Only 12.9% of breast cancer cases in sub-Saharan Africa were detected through screening, with rates varying from 5.2% in Ivory Coast to 23.1% in Namibia. | |
| Approximately 16.3% of women in sub-Saharan Africa countries underwent clinical breast cancer screening, with rates varying across countries, from 5.2% in Cote D'Ivoire to 25.5% in Kenya. | |
| In Africa, breast cancer screening detects <1 to 56 cases per 1000 women through Clinical Breast Examination (CBE) and mammography, highlighting varying detection rates. | |
| In Africa, breast cancer screening detects <1/1000 to 56/1000 cases, with Clinical Breast Examination (CBE) and mammography being the main modalities used, showing varying detection rates. | |
| Not addressed in the paper. |
Related Questions
Percentage of cervical cancer cases registered in cancer registry were detected via screening in africa?5 answersIn Africa, the percentage of cervical cancer cases detected via screening varies across different regions and time periods. Studies indicate that the screening coverage for cervical cancer remains suboptimal in Sub-Saharan Africa (SSA), with low prevalence rates reported. However, there have been improvements in screening rates in certain regions, such as Southern Africa, where screening coverages have increased over the years. Despite these improvements, only a small proportion of women have been screened at least twice by the age of 45, highlighting the ongoing challenges in achieving comprehensive screening. Efforts to increase screening coverage are crucial to detect cervical cancer cases early and improve treatment outcomes, as highlighted by the need for policymakers and healthcare workers to address barriers to screening in SSA.
What proportion of cases of breast cancer is detected through screening?5 answersApproximately 15.4% of screen-detected breast cancer cases are estimated to be overdiagnosed in contemporary mammography practice, with 6.1% attributed to detecting nonprogressive preclinical cancer and 9.3% due to detecting progressive preclinical cancer in women who would have died of an unrelated cause before clinical diagnosis. The detection rate of lymphoproliferative disease (LPD) in women undergoing routine breast cancer screening is around 2.36 per 1000 screens, with the majority of LPDs being non-aggressive and nearly a third being aggressive but detected at an early stage. The impact of the COVID-19 pandemic on breast cancer screening resulted in a decrease in the number of participants undergoing screening and a reduction in the level of cancer detection by 22.8%.
Is breast cancer common in africa?4 answersBreast cancer is a common disease in Africa, with a high mortality rate and increasing incidence. In 2018, there were approximately 627,000 breast cancer-related deaths, with sub-Saharan Africa accounting for 15% of all cancer-related deaths. Africa has one of the lowest incidence rates globally, but the highest mortality rate. The African Female Breast Cancer Epidemiology (AFBRECANE) study aims to study the genomics and epidemiology of breast cancer in Nigerian women. Early onset breast cancer is more prevalent in African women compared to other populations, with higher tumor grade and adverse outcomes. Adherence to oral anticancer medications for breast cancer treatment is suboptimal among African women, highlighting the need for interventions to improve adherence. Overall, breast cancer is a significant health problem in Africa, and there is a need for better screening, diagnostics, and treatment accessibility in resource-constrained settings.
What are the factors that affect cervical cancer screening amongst women in West Africa?5 answersFactors that affect cervical cancer screening amongst women in West Africa include poor knowledge about cervical cancer and screening, low risk perception of cervical cancer, fear of test results and fear of screening, lack of access to screening services, high cost of screening services, poor partner attitude and acceptance of the service, inadequate sensitization, and ignorance about the usefulness of screening. Other barriers include the perception of an additional burden of having a cervical cancer diagnosis. Sociodemographic factors such as age, religion, employment status, and marital status can also influence screening participation. Lack of information and forgetfulness were reported as barriers to re-screening. Developing better information approaches, increasing healthcare worker prescriptions for screening, and diversifying communication methods are recommended to improve screening participation.
What are some known technologies on breast cancer in Africa ?4 answersBreast cancer research in Africa has focused on various technologies and approaches. Next Generation Sequencing (NGS) has been used to analyze the coding regions and exon-intron junctions of BRCA1 and BRCA2 genes in young women with breast cancer in Burkina Faso, leading to the identification of pathogenic mutations and variants of uncertain clinical significance. Pharmacogenetic and pharmacokinetic studies have explored the genetic variabilities associated with the metabolism and/or transport of breast cancer drugs, with a focus on genes such as CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4/5, CYP19A1, UGT1A4, UGT2B7, UGT2B15, SLC22A16, SLC38A7, FcγR, DPYD, ABCB1, and SULT1A1. Studies have also examined the prevalence of triple negative and basal-like breast cancer in different African populations, using immunohistochemistry (IHC) to determine the absence of estrogen and progesterone receptors and HER-2 receptor overexpression. Pathology services in sub-Saharan Africa face challenges in terms of equipment, organization, and qualified personnel, with limited access to immunohistochemistry for biomarker evaluation. Overall, there is a need for larger numbers of experienced pathologists, technical staff, and standardized pathology services to improve breast cancer care in Africa.
Cancer statistics in Africa5 answersCancer statistics in Africa show that the continent is facing a growing burden of the disease. The most common cancers in Africa include breast, cervical, liver, prostate, and colorectal cancers. Infections play a significant role in cancer development, with human papillomaviruses (HPV) being the most common infection-associated cancer, particularly cervical cancer. Other infections such as Kaposi sarcoma-associated herpesvirus, hepatitis viruses (B and C), Helicobacter pylori, Epstein-Barr virus, and Schistosoma haematobium also contribute to the cancer burden in Africa. The rising life expectancy, adoption of Western lifestyles, and the prevalence of infectious diseases are factors contributing to the increasing cancer rates in Africa. However, there is a shortage of medical equipment, research resources, and well-trained medical practitioners, hindering effective cancer control and treatment in the region. Improved surveillance systems, prevention strategies, and access to treatment are needed to address the growing cancer burden in Africa.